Clinical trial shows bionic pancreas improves type 1 diabetes management compared to standard insulin delivery method
Headline from MedicalXpress
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has fou…
MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has fou…
THURSDAY, Sept. 29, 2022 (HealthDay News) -- A new technology dubbed the "bionic pancreas" may beat standard treatment in helping people with type 1 diabetes control their blood sugar levels,
'Bionic pancreas' could make life easier for people with type 1 diabetes. If approved by the FDA, the iLet Bionic Pancreas would be the most automated system available for managing
